Potential Markers of Sacubitril-Valsartan Tolerance

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.175
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Sacubitril/Valsartan Use for the Hospitalist

American Journal of Hospital Medicine
2017English

Sacubitril/Valsartan: Beyond Natriuretic Peptides

Heart
Cardiovascular MedicineCardiology
2017English

Sacubitril/Valsartan Verbessern Auch Den HbA1c-Wert

MMW Fortschritte der Medizin
Medicine
2017English

Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Reply: Sacubitril/Valsartan for Chagas' Heart Disease Heart Failure?

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Perceived Barriers to Sacubitril/Valsartan Use in Patients With Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Sacubitril/Valsartan: Evaluation of Safety and Efficacy as an Antihypertensive Treatment

Drugs in Context
Molecular MedicinePharmacology
2018English

Pcv6 - Sacubitril/Valsartan in Heart Failure: Projected Health Outcomes in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy